OSCR
Oscar Health Inc
NYSE: OSCR · HEALTHCARE · HEALTHCARE PLANS
$32.77
+0.58% today
Updated 2026-09-11
Market cap
$10.19B
P/E ratio
25.39
P/S ratio
0.67x
EPS (TTM)
$1.30
Dividend yield
—
52W range
$11 – $34
Volume
5.1M
WallStSmart proprietary scores
66
out of 100
Grade: B
Buy
Investment rating
10.0
Growth
A+5.0
Quality
C+4.5
Profitability
C5.3
Valuation
C+3/9
Piotroski F-Score
Weak
1.0
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →251 stocks currently score above 75
Price targets
Analyst target
$18,220.00
+55499.63%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
3 Strong Buy0 Buy7 Hold0 Sell1 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $2.04B — positive
+ Revenue growth 70.40% QoQ
+ Debt/equity 0.21x — low leverage
Risks
- Piotroski 3/9 — weak financial health
- Altman Z 0.96 — distress zone
- Thin margins at 3.60%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $4.13B | $5.86B | $9.18B | $11.70B | $15.32B | $18.9B |
| Net income | $-606.27M | $-270.73M | $25.43M | $-443.15M | $361.81M | — |
| EPS | — | — | — | — | $1.30 | $0.69 |
| Free cash flow | $351.34M | $-297.74M | $950.30M | $1.06B | $2.04B | — |
| Profit margin | -14.70% | -4.62% | 0.28% | -3.79% | 3.60% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-08-28 | SCHLOSSER, MARIO | Sale | 150,000 | — |
| 2026-08-28 | SCHLOSSER, MARIO | Buy | 150,000 | $9.75 |
| 2026-08-28 | SCHLOSSER, MARIO | Sale | 150,000 | $30.79 |
Peer comparison
Smart narrative
Oscar Health Inc trades at $32.77. representing a P/E of 25.39x trailing earnings. Our Smart Value Score of 66/100 indicates the stock is good. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 0.96, it sits in the distress. TTM revenue stands at $15.32B. with profit margins at 3.60%.
Frequently asked questions
What is Oscar Health Inc's stock price?
Oscar Health Inc (OSCR) trades at $32.77, on a P/E of 25.4x and a P/S of 0.7x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is Oscar Health Inc overvalued?
Oscar Health Inc carries a Smart Value Score of 66/100 (Grade B), which we rate Buy. That score blends growth, quality, and valuation into one read.
What is the price target of Oscar Health Inc (OSCR)?
The 12-month analyst consensus target is $18,220.00, about 55499.6% above the current $32.77. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of OSCR by 2030?
Our research-backed model puts the 2030 base case at $47.62, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is Oscar Health Inc's revenue?
Oscar Health Inc's trailing twelve-month revenue is $15.32B, and our model projects it reaching about $27.00B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
Oscar Health Inc's Altman Z-Score is 0.96, which places it in the distress. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryHEALTHCARE PLANS
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.67x
ROE-2.37%
Beta2.37
50D MA$30.40
200D MA$20.49
Shares out0.27B
Float0.26B
Short ratio—
Avg volume5.1M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—